When comparing gene expression levels of HOXA9, MEIS1, CMYC and BCL2 across the broad leukemia cell line panel, no significant differences could be detected in baseline expression levels of the four genes between leukemia cell lines sensitive and resistant to CCI-007 (Supplementary Figure S5A). This evidence concerns the gene BCL2 and leukemia.